Physician profile
Alberto Pinzon Ardila
NPI 1154643120
$143,770.79
in general payments reported to CMS, 2019-2025
81 companies · $20K in 2025
The $20K reported for 2025 was more than what 94% of Epilepsy providers received nationally (typical 2025 total: $366).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,388 · 2020: $15K · 2021: $14K · 2022: $27K · 2023: $31K · 2024: $25K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Food and Beverage: $23K · Honoraria: $11K · Consulting Fee: $6,626 · Travel and Lodging: $4,173 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $32,840.00 |
| Food and Beverage | $22,864.61 |
| Honoraria | $10,500.00 |
| Consulting Fee | $6,626.22 |
| Travel and Lodging | $4,172.54 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $63,994.88 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Sk Life Science, INC. | $40,527.21 | 2020-2024 | Xcopri |
| Livanova USA, INC. | $8,444.95 | 2019-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Jazz Pharmaceuticals INC. | $4,903.98 | 2021-2025 | |
| Abbvie INC. | $3,632.26 | 2021-2025 | |
| Ucb Sa | $2,688.72 | 2025 | |
| Abbott Laboratories | $1,973.21 | 2020-2025 | Infinity, Proclaim |
| Amgen INC. | $1,384.71 | 2019-2025 | Uplizna |
| Greenwich Biosciences, INC. | $994.25 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $978.01 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Eisai INC. | $973.80 | 2019-2025 | |
| Lilly USA, LLC | $849.09 | 2019-2025 | Kisunla, Amyvid, Zepbound |
| Novartis Pharmaceuticals Corporation | $743.55 | 2020-2025 | |
| Mallinckrodt Hospital Products INC. | $630.76 | 2020-2025 | Acthar |
| Otsuka America Pharmaceutical, INC. | $516.16 | 2023-2024 | Rexulti |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $507.96 | 2020-2025 | Ingrezza, Ongentys |
| Neurelis, INC. | $499.49 | 2020-2025 | Valtoco |
| Pfizer INC. | $483.48 | 2023-2025 | |
| Emd Serono, INC. | $473.69 | 2023-2025 | Mavenclad, Mavenclad |
| Lundbeck LLC | $471.46 | 2020-2025 | Vyepti, Rexulti |
| Allergan, INC. | $441.64 | 2019-2022 | |
| Harmony Biosciences LLC | $425.13 | 2020-2025 | Wakix |
| Argenx US, INC. | $410.60 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Adamas Pharmaceuticals, INC. | $383.08 | 2019-2021 | |
| Almatica Pharma LLC | $370.87 | 2021-2023 | Gralise |
| Biohaven Pharmaceuticals, INC. | $341.14 | 2020-2021 | |
| Tanabe Pharma America, INC. | $325.85 | 2019-2025 | Radicava |
| Alexion Pharmaceuticals, INC. | $295.25 | 2021-2025 | Ultomiris |
| Acorda Therapeutics, INC | $276.44 | 2019-2024 | Inbrija |
| Sunovion Pharmaceuticals INC. | $259.45 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $243.71 | 2022-2024 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $239.67 | 2023-2025 | Hyqvia |
| Kyowa Kirin, INC. | $234.48 | 2019-2024 | Nourianz |
| Biogen, INC. | $198.56 | 2021-2025 | Tysabri, Vumerity, Plegridy |
| Neuropace, INC. | $194.21 | 2019-2024 | |
| Tg Therapeutics, INC. | $178.90 | 2023-2025 | |
| Merz Pharmaceuticals, LLC | $175.88 | 2022-2025 | Xeomin, Inbrija, Ampyra |
| Inspire Medical Systems, INC. | $172.23 | 2024 | Inspire |
| Sumitomo Pharma America, INC. | $169.27 | 2023-2024 | Aptiom |
| Scilex Pharmaceuticals INC. | $168.63 | 2023-2024 | Ztlido |
| Axsome Therapeutics, INC. | $157.03 | 2024-2025 | Sunosi |
| Immedica Pharma US, INC. | $145.30 | 2023-2025 | Ztalmy |
| Insightec,INC | $138.96 | 2023 | Exablate |
| Astrazeneca Pharmaceuticals Lp | $132.06 | 2021-2025 | Wainua |
| Amneal Pharmaceuticals LLC | $131.78 | 2024-2025 | Crexont, Ongentys, Ongentys 50mg Capsules 30 |
| Aquestive Therapeutics, INC. | $128.73 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $125.87 | 2022 | |
| Genentech USA, INC. | $120.15 | 2024-2025 | Ocrevus Zunovo, Ocrevus |
| Octapharma USA, INC. | $108.99 | 2022-2024 | Panzyga |
| Janssen Pharmaceuticals, INC | $100.18 | 2022-2023 | Ponvory |
| Zyla Life Sciences, INC. | $98.71 | 2019-2020 | |
| Aprecia Pharmaceuticals, LLC | $97.23 | 2021-2023 | Spritam |
| Avadel Cns Pharmaceuticals, LLC | $88.88 | 2024-2025 | Lumryz |
| Boston Scientific Corporation | $88.86 | 2019-2023 | Watchman Flx |
| Supernus Pharmaceuticals, INC. | $80.03 | 2020-2022 | |
| Avanir Pharmaceuticals, INC. | $75.70 | 2019 | |
| Averitas Pharma INC. | $71.28 | 2023-2025 | Qutenza |
| Banner Life Sciences, LLC | $68.29 | 2021-2024 | |
| Vanda Pharmaceuticals INC. | $63.26 | 2020-2025 | Ponvory |
| Avion Pharmaceuticals | $62.45 | 2022-2023 | Dhivy |
| Upsher-Smith Laboratories LLC | $53.59 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $52.46 | 2019-2022 | |
| Cycle Pharmaceuticals INC | $51.61 | 2025 | Bafiertam |
| Janssen Biotech, INC. | $44.36 | 2025 | |
| Grifols USA, LLC | $35.06 | 2020-2021 | |
| Catalyst Pharmaceuticals, INC. | $34.81 | 2023 | Fycompa |
| Itamar Medical INC | $25.82 | 2023 | Watchpatone |
| Currax Pharmaceuticals LLC | $23.14 | 2021 | |
| Xeris Pharmaceuticals, INC. | $21.39 | 2025 | Keveyis |
| Tris Pharma INC | $21.25 | 2024 | Dyanavel Xr |
| Alfasigma USA, INC. | $20.91 | 2022 | |
| Vertical Pharmaceuticals, LLC | $18.71 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.42 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.69 | 2020 | |
| Ricoh USA, INC | $13.79 | 2019 | |
| Assertio Therapeutics, INC. | $13.53 | 2019 | |
| Celgene Corporation | $12.30 | 2020 | |
| Life Molecular Imaging Ltd | $11.83 | 2019 | |
| Ge Healthcare | $11.77 | 2021 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Pinzon Ardila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.